Avacta Group (AVCT)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 45.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 159.60
  • 52 Week Low: 43.00
  • Currency: UK Pounds
  • Shares Issued: 359.04m
  • Volume: 0
  • Market Cap: £163.36m
  • RiskGrade: 461

Latest ShareCast News

Avacta reaches milestone in AVA6000 dose escalation

By Josh White

Date: Thursday 21 Mar 2024

(Sharecast News) - Avacta Group announced a significant milestone in its phase 1a dose escalation study of AVA6000, its lead 'preCISION' drug, on Thursday.

Avacta tumbles after raising £25.7m in heavily discounted placing

By Michele Maatouk

Date: Thursday 29 Feb 2024

(Sharecast News) - Healthcare therapeutics company Avacta tumbled on Thursday after a heavily discounted placing.

Avacta appoints new head of research and development

By Josh White

Date: Friday 19 Jan 2024

(Sharecast News) - Oncology drugs and diagnostics developer Avacta announced the appointment of Dr Christina Coughlin as its new head of research and development for the therapeutics division on Friday.

Avacta appoints new chief business officer 19-Dec-2023 ShareCast
Avacta hails "encouraging" clinical data from ca... 13-Dec-2023 ShareCast
Avacta reports higher losses in first half 28-Sep-2023 ShareCast
Avacta brings in clinical consultant as it hunts... 20-Sep-2023 ShareCast
Avacta upbeat on fresh data from chemotherapy tr... 19-Sep-2023 ShareCast
Avacta completes fifth dose escalation in chemot... 21-Jun-2023 ShareCast
Avacta denies press speculation over potential f... 19-Jun-2023 ShareCast
Avacta triggers second milestone payment in Affy... 05-Jun-2023 ShareCast
Avacta buys Belgium-based Coris Bioconcept for £... 01-Jun-2023 ShareCast
Avacta doses first patient in US tumour treatmen... 27-Apr-2023 ShareCast
Revenue rises, adjusted EBITDA loss improves for... 25-Apr-2023 ShareCast
Avacta presents pre-clinical data for anti-cance... 17-Apr-2023 ShareCast
Avacta opens first US clinical investigator sites 06-Apr-2023 ShareCast
Avacta doses first patient in higher-dose oncolo... 05-Apr-2023 ShareCast
Avacta to present tumour medicine data at cancer... 27-Mar-2023 ShareCast
Avacta has 'no relationship' with failed tech-fo... 13-Mar-2023 ShareCast
Avacta reports positive progress in chemotherapy... 17-Jan-2023 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Avacta Group Market Data

Currency UK Pounds
Share Price 45.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 159.60
52 Week Low 43.00
Volume 0
Shares Issued 359.04m
Market Cap £163.36m
RiskGrade 461

Avacta Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.43% below the market average34.43% below the market average34.43% below the market average34.43% below the market average34.43% below the market average
45.1% below the sector average45.1% below the sector average45.1% below the sector average45.1% below the sector average45.1% below the sector average
Price Trend
86.37% below the market average86.37% below the market average86.37% below the market average86.37% below the market average86.37% below the market average
48.15% below the sector average48.15% below the sector average48.15% below the sector average48.15% below the sector average48.15% below the sector average
Income Not Available
Growth
62.22% above the market average62.22% above the market average62.22% above the market average62.22% above the market average62.22% above the market average
82.35% above the sector average82.35% above the sector average82.35% above the sector average82.35% above the sector average82.35% above the sector average

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 0
Sell 0
Strong Sell 1
Total 3
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Avacta Group Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Avacta Group Key Personnel

CFO Tony Peter Gardiner
CEO Christina Coughlin

Top of Page